Research led by Prof. Ryan Jensen at Yale Medical School focuses on elucidating the links between BRCA gene mutations and breast cancer. Learn how researchers in his lab use Bio-Rad’s V3 Western Workflow to study interactions between BRCA proteins and the DNA repair protein RAD51. Understanding how these proteins interact in carcinogenesis and tumor growth will provide a new understanding of breast cancer mechanisms that could lead to new therapies.

Previous post

Revealing BRCA2 Pathways in Cancer with Bio-Rad's V3 Western Workflow

Next post

Digital Quantitation of Potential Therapeutic Target RNAs